These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1134 related items for PubMed ID: 11907109

  • 1. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N, Brooks AD, Carter CR, Back TC, Parsoneault EM, Smyth MJ, Wiltrout RH, Sayers TJ.
    J Immunol; 2002 Apr 01; 168(7):3484-92. PubMed ID: 11907109
    [Abstract] [Full Text] [Related]

  • 2. The Fas/Fas ligand pathway is important for optimal tumor regression in a mouse model of CTL adoptive immunotherapy of experimental CMS4 lung metastases.
    Caldwell SA, Ryan MH, McDuffie E, Abrams SI.
    J Immunol; 2003 Sep 01; 171(5):2402-12. PubMed ID: 12928387
    [Abstract] [Full Text] [Related]

  • 3. T cell lysis of murine renal cancer: multiple signaling pathways for cell death via Fas.
    Sayers TJ, Brooks AD, Seki N, Smyth MJ, Yagita H, Blazar BR, Malyguine AM.
    J Leukoc Biol; 2000 Jul 01; 68(1):81-6. PubMed ID: 10914493
    [Abstract] [Full Text] [Related]

  • 4. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
    Saha A, Chatterjee SK, Foon KA, Bhattacharya-Chatterjee M.
    Immunology; 2006 Aug 01; 118(4):483-96. PubMed ID: 16895556
    [Abstract] [Full Text] [Related]

  • 5. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
    Sayers TJ, Brooks AD, Lee JK, Fenton RG, Komschlies KL, Wigginton JM, Winkler-Pickett R, Wiltrout RH.
    J Immunol; 1998 Oct 15; 161(8):3957-65. PubMed ID: 9780164
    [Abstract] [Full Text] [Related]

  • 6. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
    Frost PJ, Butterfield LH, Dissette VB, Economou JS, Bonavida B.
    J Immunol; 2001 Mar 01; 166(5):3564-73. PubMed ID: 11207317
    [Abstract] [Full Text] [Related]

  • 7. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).
    Winter H, Hu HM, Urba WJ, Fox BA.
    J Immunol; 1999 Oct 15; 163(8):4462-72. PubMed ID: 10510388
    [Abstract] [Full Text] [Related]

  • 8. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.
    Lee SH, Bar-Haim E, Machlenkin A, Goldberger O, Volovitz I, Vadai E, Tzehoval E, Eisenbach L.
    Cancer Gene Ther; 2004 Mar 15; 11(3):237-48. PubMed ID: 14739939
    [Abstract] [Full Text] [Related]

  • 9. Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.
    Kafrouni MI, Brown GR, Thiele DL.
    J Immunol; 2001 Aug 01; 167(3):1566-74. PubMed ID: 11466378
    [Abstract] [Full Text] [Related]

  • 10. Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways.
    Yang S, Haluska FG.
    J Immunol; 2004 Apr 01; 172(7):4599-608. PubMed ID: 15034078
    [Abstract] [Full Text] [Related]

  • 11. Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity.
    Medana I, Li Z, Flügel A, Tschopp J, Wekerle H, Neumann H.
    J Immunol; 2001 Jul 15; 167(2):674-81. PubMed ID: 11441070
    [Abstract] [Full Text] [Related]

  • 12. IFN-gamma promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells.
    Roth E, Pircher H.
    J Immunol; 2004 Feb 01; 172(3):1588-94. PubMed ID: 14734739
    [Abstract] [Full Text] [Related]

  • 13. TNF plays an essential role in tumor regression after adoptive transfer of perforin/IFN-gamma double knockout effector T cells.
    Poehlein CH, Hu HM, Yamada J, Assmann I, Alvord WG, Urba WJ, Fox BA.
    J Immunol; 2003 Feb 15; 170(4):2004-13. PubMed ID: 12574370
    [Abstract] [Full Text] [Related]

  • 14. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
    Dobrzanski MJ, Reome JB, Hollenbaugh JA, Dutton RW.
    J Immunol; 2004 Feb 01; 172(3):1380-90. PubMed ID: 14734713
    [Abstract] [Full Text] [Related]

  • 15. Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTL.
    Bergmann-Leitner ES, Abrams SI.
    J Immunol; 2000 May 01; 164(9):4941-54. PubMed ID: 10779805
    [Abstract] [Full Text] [Related]

  • 16. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
    Mitsui T, Miyake Y, Kakeya H, Osada H, Kataoka T.
    J Immunol; 2004 Mar 15; 172(6):3428-36. PubMed ID: 15004142
    [Abstract] [Full Text] [Related]

  • 17. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting Fas ligand expression.
    Delgado M, Ganea D.
    J Immunol; 2000 Jul 01; 165(1):114-23. PubMed ID: 10861043
    [Abstract] [Full Text] [Related]

  • 18. Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.
    Yanai F, Ishii E, Kojima K, Hasegawa A, Azuma T, Hirose S, Suga N, Mitsudome A, Zaitsu M, Ishida Y, Shirakata Y, Sayama K, Hashimoto K, Yasukawa M.
    J Immunol; 2003 Feb 15; 170(4):2205-13. PubMed ID: 12574394
    [Abstract] [Full Text] [Related]

  • 19. Redirected perforin-dependent lysis of colon carcinoma by ex vivo genetically engineered CTL.
    Darcy PK, Haynes NM, Snook MB, Trapani JA, Cerruti L, Jane SM, Smyth MJ.
    J Immunol; 2000 Apr 01; 164(7):3705-12. PubMed ID: 10725729
    [Abstract] [Full Text] [Related]

  • 20. NK cells use NKG2D to recognize a mouse renal cancer (Renca), yet require intercellular adhesion molecule-1 expression on the tumor cells for optimal perforin-dependent effector function.
    Abdool K, Cretney E, Brooks AD, Kelly JM, Swann J, Shanker A, Bere EW, Yokoyama WM, Ortaldo JR, Smyth MJ, Sayers TJ.
    J Immunol; 2006 Aug 15; 177(4):2575-83. PubMed ID: 16888019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.